The Cigna Group
CI
$298.49
$9.423.26%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 276.88B | 273.85B | 267.09B | 261.19B | 254.45B |
| Total Other Revenue | 1.01B | 1.05B | 984.00M | 836.00M | 921.00M |
| Total Revenue | 277.89B | 274.90B | 268.08B | 262.02B | 255.37B |
| Cost of Revenue | 252.47B | 249.34B | 242.47B | 236.19B | 229.18B |
| Gross Profit | 25.42B | 25.56B | 25.61B | 25.83B | 26.19B |
| SG&A Expenses | 12.15B | 13.62B | 13.99B | 14.35B | 14.70B |
| Depreciation & Amortization | 1.71B | 1.74B | 1.70B | 1.70B | 1.70B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 266.32B | 264.70B | 258.16B | 252.25B | 245.58B |
| Operating Income | 11.57B | 10.20B | 9.91B | 9.78B | 9.78B |
| Income Before Tax | 8.40B | 7.78B | 7.97B | 6.87B | 6.84B |
| Income Tax Expenses | 1.66B | 1.49B | 1.42B | 1.47B | 1.44B |
| Earnings from Continuing Operations | 6.74K | 6.29K | 6.55K | 5.40K | 5.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -452.00M | -331.00M | -403.00M | -384.00M | -365.00M |
| Net Income | 6.29B | 5.96B | 6.15B | 5.02B | 5.03B |
| EBIT | 11.57B | 10.20B | 9.91B | 9.78B | 9.78B |
| EBITDA | 14.32B | 12.98B | 12.61B | 12.43B | 12.49B |
| EPS Basic | 23.75 | 22.34 | 22.79 | 18.42 | 18.17 |
| Normalized Basic EPS | 22.31 | 19.37 | 18.22 | 17.67 | 17.42 |
| EPS Diluted | 23.60 | 22.19 | 22.66 | 18.31 | 18.05 |
| Normalized Diluted EPS | 22.18 | 19.24 | 18.12 | 17.55 | 17.30 |
| Average Basic Shares Outstanding | 1.06B | 1.07B | 1.08B | 1.09B | 1.11B |
| Average Diluted Shares Outstanding | 1.07B | 1.07B | 1.09B | 1.10B | 1.12B |
| Dividend Per Share | 6.09 | 6.04 | 5.93 | 5.82 | 5.71 |
| Payout Ratio | 25.70% | 27.04% | 26.01% | 31.63% | 31.35% |